Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety study of ME-609 for recurrent herpes simplex labialis in adolescents
2006-002828-42Phase 3Completed
- Sponsor
- Medivir
- Start
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of acyclovir + hydrocortisone in herpes labialis, sponsored by Medivir. Primary endpoint: Adverse events. Started Aug 2006; status: completed.
02
Drugs
acyclovir + hydrocortisone
03
Conditions
herpes labialis
Beyond the preview
Go deeper on 2006-002828-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002828-42.